ArticleStem cell research & therapy2022

Intrauterine infusion of clinically graded human umbilical cord-derived mesenchymal stem cells for the treatment of poor healing after uterine injury: a phase I clinical trial.

Jingrui Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.